Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,068 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Methods for managing miscarriage: a network meta-analysis.
Ghosh J, Papadopoulou A, Devall AJ, Jeffery HC, Beeson LE, Do V, Price MJ, Tobias A, Tunçalp Ö, Lavelanet A, Gülmezoglu AM, Coomarasamy A, Gallos ID. Ghosh J, et al. Cochrane Database Syst Rev. 2021 Jun 1;6(6):CD012602. doi: 10.1002/14651858.CD012602.pub2. Cochrane Database Syst Rev. 2021. PMID: 34061352 Free PMC article.
Practical Consensus Guidelines for the Use of S-1 in GI Malignancies.
Parikh PM, Sahoo TP, Biswas G, Talwar V, Sp S, Panda SS, Cb A, Shetty N, Ramesh A, Ghosh J, Shetty VV, Naik R, Singh A, Gupta G, Parekh B. Parikh PM, et al. Among authors: ghosh j. South Asian J Cancer. 2024 Feb 5;13(1):77-82. doi: 10.1055/s-0043-1778685. eCollection 2024 Jan. South Asian J Cancer. 2024. PMID: 38721104 Free PMC article.
Clinical outcomes of adaptive intracavitary and interstitial brachytherapy technique in locally advanced cervical cancer: A real-world data.
Kashid SR, Gurram L, Pullan S, Chopra S, Mittal P, Ghadi Y, Dheera A, Scaria L, Kohle S, Kadam S, Ghosh J, Rath S, Gupta S, Mahantshetty U. Kashid SR, et al. Among authors: ghosh j. Brachytherapy. 2024 Apr 18:S1538-4721(24)00047-3. doi: 10.1016/j.brachy.2024.03.006. Online ahead of print. Brachytherapy. 2024. PMID: 38641455
Real world study of safety and efficacy of lorlatinib as second line and beyond in ALK-rearranged advanced non-small cell lung cancer patients in India - a multicentre chart review study (ROSELAND).
Biswas B, Ghadyalpatil NS, Patil S, Patel A, Ganguly S, Rathore A, Guleria B, Tarannum CF, Ghosh J, Kondapally MS, Thippeswamy R, Reddy SHP, Roy S. Biswas B, et al. Among authors: ghosh j. Ecancermedicalscience. 2024 Feb 13;18:1667. doi: 10.3332/ecancer.2024.1667. eCollection 2024. Ecancermedicalscience. 2024. PMID: 38439810 Free PMC article.
1,068 results